Results 31 to 40 of about 191,653 (254)

Myocardial Architecture, Mechanics, and Fibrosis in Congenital Heart Disease

Frontiers in Cardiovascular Medicine, 2017
Congenital heart disease (CHD) is the most common category of birth defect, affecting 1% of the population and requiring cardiovascular surgery in the first months of life in many patients. Due to advances in congenital cardiovascular surgery and patient
Sarah Ghonim, Sarah Ghonim, Sarah Ghonim, Inga Voges, Inga Voges, Peter D. Gatehouse, Jennifer Keegan, Michael A. Gatzoulis, Michael A. Gatzoulis, Philip J. Kilner, Sonya V. Babu-Narayan, Sonya V. Babu-Narayan, Sonya V. Babu-Narayan   +12 more
doaj   +1 more source

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study

Journal of Cardiovascular Magnetic Resonance, 2021
Background Left atrial (LA) size and function are known predictors of new onset atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients.
Betty Raman, Robert W. Smillie, Masliza Mahmod, Kenneth Chan, Rina Ariga, Chrysovalantou Nikolaidou, Elizabeth Ormondroyd, Kate Thomson, Andrew R. Harper, Gifford Tan, Adam J. Lewandowski, Fernando Rodriguez Bajo, Eleanor C. Wicks, Barbara Casadei, Hugh Watkins, Stefan Neubauer   +15 more
doaj   +1 more source

Test-retest variability of left ventricular 4D flow cardiovascular magnetic resonance measurements in healthy subjects

Journal of Cardiovascular Magnetic Resonance, 2018
Background Quantification and visualisation of left ventricular (LV) blood flow is afforded by three-dimensional, time resolved phase contrast cardiovascular magnetic resonance (CMR 4D flow). However, few data exist upon the repeatability and variability
Victoria M. Stoll, Margaret Loudon, Jonatan Eriksson, Malenka M. Bissell, Petter Dyverfeldt, Tino Ebbers, Saul G. Myerson, Stefan Neubauer, Carl- Johan Carlhäll, Aaron T. Hess   +9 more
doaj   +1 more source

Quality control-driven deep ensemble for accountable automated segmentation of cardiac magnetic resonance LGE and VNE images

Frontiers in Cardiovascular Medicine, 2023
BackgroundLate gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging is the gold standard for non-invasive myocardial tissue characterisation.
Ricardo A. Gonzales, Daniel H. Ibáñez, Daniel H. Ibáñez, Evan Hann, Iulia A. Popescu, Matthew K. Burrage, Matthew K. Burrage, Yung P. Lee, İbrahim Altun, William S. Weintraub, Raymond Y. Kwong, Christopher M. Kramer, Stefan Neubauer, Hypertrophic Cardiomyopathy Registry (HCMR) Investigators, Oxford Acute Myocardial Infarction (OxAMI) Study, Vanessa M. Ferreira, Qiang Zhang, Stefan K. Piechnik   +17 more
doaj   +1 more source

A young man with typical STEMI presentation: A case of myocarditis A Cardiac MRI Diagnosis

Majalah Kardiologi Indonesia, 2013
A 19 years old man, originated from Kongo, presented to a hospital with acute chest pain since several hours before admission. The pain was sharp in quality, distributed in the middle of left chest, not exercise related and not radiating.
Saskia D Handari, Joseph B Selvanayagam
doaj   +1 more source

Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study

BMC Cardiovascular Disorders, 2022
Background The role of the dysfunction of left atrium in the occurrence and development of cardiovascular disease has been gradually recognized. We aim to compare the impact on left atrial (LA) function between patients with hypertrophic cardiomyopathy ...
Di Zhou, Wenjing Yang, Yingxia Yang, Gang Yin, Shuang Li, Baiyan Zhuang, Jing Xu, Jian He, Weichun Wu, Yong Jiang, Xiaoxin Sun, Yining Wang, Arlene Sirajuddin, Shihua Zhao, Minjie Lu   +14 more
doaj   +1 more source

Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential

FEBS Letters, EarlyView.
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta, Hari Baskar Balasubramanian, Amir Pasokh, Marietta Zille   +3 more
wiley   +1 more source

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal ...
Rebecca K. Hughes, Claudia Camaioni, João B. Augusto, Kristopher Knott, Ellie Quinn, Gabriella Captur, Andreas Seraphim, George Joy, Petros Syrris, Perry M. Elliott, Saidi Mohiddin, Peter Kellman, Hui Xue, Luis R. Lopes, James C. Moon   +14 more
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging

Case Reports in Cardiology, 2012
Giant cell myocarditis, but not cardiac sarcoidosis, is known to cause fulminant myocarditis resulting in severe heart failure. However, giant cell myocarditis and cardiac sarcoidosis are pathologically similar, and attempts at pathological ...
Hari Bogabathina, Peter Olson, Vikas K. Rathi, Robert W. W. Biederman   +3 more
doaj   +1 more source